Back to results
US 2016/0100795 A1Published application
System and Method for Evaluation of Disease Burden
AssigneeWisconsin Alumni Research Foundation
InventorsRobert Jeraj, Glenn Liu
Life of this patent
Estimating the term…
Abstract
A sensitive method of assessing treatment using molecular and anatomical imaging scans provides automatic tumor identification and quantification within anatomical zones based on treatment criteria. Absolute or comparative measures of tumors in pre- and/or post-scans are thereby isolated from other tissue to accentuate the progress of the treatment when multiple scattered disease lesions are present.
Claims22
A method of assessing treatment of a patient comprising the steps of:
- acquiring a scan of a molecular imaging agent uptake of tissue of the patient, the molecular imaging agent uptake identifying diseased tissue;
- processing the scan using an electronic computer executing a stored program to:
- (a) receive an input describing at least one of disease type and molecular imaging agent type;
- (b) process the input to produce a set of anatomical regions of interest based on the input, the anatomical regions of interest representing a subset of a region of the scan;
- (c) identify multiple disease locations within the anatomical regions based on molecular imaging agent uptake indicated by the scan;
- provide an output indicating disease progression/regression based on measures of molecular imaging agent uptake within the multiple disease locations isolated from molecular imaging agent uptake outside of the multiple disease locations.
3 more elements
An apparatus for assessing cancer treatment of a patient comprising:
- an electronic computer executing a stored program to:
- (a) receive a scan of molecular imaging agent uptake of tissue of the patient, the molecular imaging agent identifying disease tissue;
- (b) receive an input describing at least one of cancer type and molecular imaging agent type;
- (c) process the input to produce a set of anatomical regions of interest based on the input, the anatomical regions of interest representing a subset of a region of the scan;
- (d) identify multiple disease locations within the anatomical regions based on molecular imaging agent uptake indicated by the scan;
- and
- (e) output an indication of cancer progression/regression based on measures of molecular imaging agent uptake within the multiple disease locations isolated from molecular imaging agent uptake outside of the multiple disease locations.
4 more elements
Dependencies are inferred from the claim text.